Evidence map›Paper›PMID 41541711›Full record

ArticleRSC medicinal chemistry2026

Revealing deamidation and isoaspartate formation during peptide analysis, purification and storage by tandem mass spectrometry.

V Erckes, L Chamera Rendueles, A Misiek, C Steuer

Abstract read
In one paragraph

Article in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

V ErckesLaboratory of Pharmaceutical Analytics, ETH Zurich, Institute of Pharmaceutical Sciences Zurich Switzerland christian.steuer@pharma.ethz.ch.ORCID https://orcid.org/0000-0002-9650-4160
L Chamera RenduelesLaboratory of Pharmaceutical Analytics, ETH Zurich, Institute of Pharmaceutical Sciences Zurich Switzerland christian.steuer@pharma.ethz.ch.ORCID https://orcid.org/0009-0009-6064-8654
A MisiekLaboratory of Pharmaceutical Analytics, ETH Zurich, Institute of Pharmaceutical Sciences Zurich Switzerland christian.steuer@pharma.ethz.ch.
C SteuerLaboratory of Pharmaceutical Analytics, ETH Zurich, Institute of Pharmaceutical Sciences Zurich Switzerland christian.steuer@pharma.ethz.ch.ORCID https://orcid.org/0000-0002-6102-3367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest in peptides and peptidomimetics continues to grow, particularly in the context of drug discovery and development. However, spontaneous chemical modifications such as deamidation and isoaspartate formation present significant challenges, as they are difficult to detect and can compromise peptide integrity and function. Conventional chromatographic methods and standard mass spectrometric analyses often fail to distinguish structurally similar peptides with nearly identical physicochemical properties and masses. In this study, tandem mass spectrometry (MS/MS) was employed to monitor deamidation events involving asparagine, glutamine and C-terminal amide functional groups. Both collision-induced dissociation (CID) and electron-transfer dissociation (ETD) were systematically evaluated and could differentiate the resulting species without relying on chromatographic separation, with ETD further enabling semi-quantitative detection of deamidation and isoaspartate formation. Using this approach, we confirmed isoaspartate formation under mildly basic conditions such as phosphate-buffered saline, whereas amidated peptides remained stable in neutral aqueous-organic mixtures or at lower temperatures. In contrast, exposure to acidic conditions, particularly in the presence of the additive trifluoroacetic acid, as commonly used during HPLC purification, resulted in substantial direct deamidation by hydrolysis without detectable isoaspartate formation. Notably, this degradation showed clear site dependence, with especially C-terminal amides, being markedly more susceptible in our study. These findings underscore how readily deamidation and isoaspartate formation can occur under routine laboratory conditions and highlight the utility of CID and ETD mass spectrometry for reliably detecting these modifications. The study emphasizes the need for careful analytical monitoring during peptide synthesis and purification to avoid misinterpretation of structural integrity.

Identifiers

PMID41541711
PMCPMC12801052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.